- Home
- RXST vs SABA Comparison
RXST vs SABA Comparison
Compare RXST & SABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXST
- SABA
- Stock Information
- Founded
- RXST 1997
- SABA 1988
- Country
- RXST United States
- SABA United States
- Employees
- RXST N/A
- SABA N/A
- Industry
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- SABA
- Sector
- RXST Health Care
- SABA
- Exchange
- RXST Nasdaq
- SABA Nasdaq
- Market Cap
- RXST 317.0M
- SABA 254.3M
- IPO Year
- RXST 2021
- SABA N/A
- Fundamental
- Price
- RXST $9.28
- SABA $9.24
- Analyst Decision
- RXST Hold
- SABA
- Analyst Count
- RXST 11
- SABA 0
- Target Price
- RXST $11.80
- SABA N/A
- AVG Volume (30 Days)
- RXST 1.1M
- SABA 290.0K
- Earning Date
- RXST 08-07-2025
- SABA 01-01-0001
- Dividend Yield
- RXST N/A
- SABA 12.91%
- EPS Growth
- RXST N/A
- SABA N/A
- EPS
- RXST N/A
- SABA N/A
- Revenue
- RXST $147,059,000.00
- SABA N/A
- Revenue This Year
- RXST N/A
- SABA N/A
- Revenue Next Year
- RXST $10.73
- SABA N/A
- P/E Ratio
- RXST N/A
- SABA N/A
- Revenue Growth
- RXST 27.68
- SABA N/A
- 52 Week Low
- RXST $6.32
- SABA $3.64
- 52 Week High
- RXST $58.23
- SABA $4.42
- Technical
- Relative Strength Index (RSI)
- RXST 57.62
- SABA 49.45
- Support Level
- RXST $8.20
- SABA $9.12
- Resistance Level
- RXST $8.87
- SABA $9.35
- Average True Range (ATR)
- RXST 0.58
- SABA 0.10
- MACD
- RXST 0.33
- SABA -0.03
- Stochastic Oscillator
- RXST 96.73
- SABA 35.29
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
About SABA Saba Capital Income & Opportunities Fund II Shares of Beneficial Interest
Saba Capital Income & Opportunities Fund II is a closed-end fund. The company seeks high current income, with a secondary goal of capital appreciation. The fund invests in fixed income markets across the globe.